CrossrefInfokarte
DPT has potential to be a prognostic biomarker and its correlation with immune infiltrates in prostate cancer
American Journal of Clinical and Experimental Immunology · 2025
DOI: 10.62347/bthg8733 ↗Abstract
Kein Abstract verfügbar.
EUVIMED